SINTX TechnologiesSINT +3.78%27 EBIT per Share is $-3.37 as of Mar. 2026. GuruFocus rates SINT with a GF Score™ of 27/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 691 Medical Devices & Instruments companies, SINTX Technologies ranks better than 98.12% on this metric.
SINTX Technologies's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.70.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.37.
During the past 3 years, the average EBIT per Share Growth Rate was 91.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 82.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for SINTX Technologies's EBIT per Share or its related term are showing as below:
SINT'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 60.4 Med: 89.5 Max: 91.2
Current: 91.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of SINTX Technologies was 91.20% per year. The lowest was 60.40% per year. And the median was 89.50% per year.
SINT's 3-Year EBIT Growth Rate is ranked better than 98.12% of 691
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs SINT: 91.20
SINTX Technologies (NAS:SINT) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
SINTX Technologies EBIT per Share Related Terms
SINTX Technologies EBIT per Share Historical Data
* Premium members only.
The historical data trend for SINTX Technologies's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.37
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SINTX Technologies (SINT) has a EBIT per Share of $-3.37 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on SINTX Technologies and its competitors. According to the industry distribution chart, SINTX Technologies ranks #13 out of 691 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is SINTX Technologies' EBIT per Share too high?
SINTX Technologies' current EBIT per Share is $-3.37. Based on the distribution chart, SINTX Technologies ranks #13 out of 691 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SINTX Technologies has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SINTX Technologies' EBIT per Share compare to VVOS and AIDX?
According to the Medical Devices & Instruments industry distribution chart, SINTX Technologies ranks #13 out of 691 companies for EBIT per Share. This places SINTX Technologies in the top 2% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 691 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on SINTX Technologies and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SINTX Technologies's current EBIT per Share is $-3.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SINTX Technologies stock overvalued right now?
Based on GuruFocus' analysis, SINTX Technologies (SINT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $1.93 — trading 1186.7% above its estimated fair value. The current EBIT per Share is $-3.37. SINTX Technologies' overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For SINTX Technologies (SINT), the current EBIT per Share is $-3.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SINTX Technologies (SINT) Overvalued in 2026?
Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued.
The current stock price of $1.93 is trading 1186.7% above its estimated GF Value™ of $0.15.
GuruFocus considers SINTX Technologies to be Significantly Overvalued.
Key valuation signals for SINT:
EBIT per Share: $-3.37
GF Value™: $0.15 vs. price of $1.93 (1186.7% above fair value)
No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
27GF Score
Get the complete analysis for SINT
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SINT has been successfully added to your 
